31 - CVS Pivots to Transparent Pricing | Pharma Leveraging Data Science | Google Unveils New AI tool | Small VC Funds Perform Best

In this episode, we discuss CVS's move toward transparent pricing, the pharmaceutical industry's embrace of data science, Google's latest AI tool, the success of small VC funds, and an outlook on healthcare for 2024.

Please check out our Episode Resources below:

------🔎RESOURCES🔎


Biden Announces Actions to Lower Health Care and Drug Costs (White House) // https://bit.ly/3NktJ5h

CVS Says It Will Change the Way Its Pharmacies Are Paid (NYT) // https://bit.ly/46Q7yei

Roche to Buy Carmot Therapeutics for Up to $3.1 Billion in Bet on Obesity Treatments (WSJ) // https://on.wsj.com/3GyJORd

J&J Hired Thousands of Data Scientists. Will The Strategy Pay Off? (WSJ) // https://on.wsj.com/3ta2svo

AstraZeneca launches Evinova, a health-tech business to accelerate innovation (MobiHealth) // https://bit.ly/48a1Uo9

Google Gemini Launches (CNET) // https://cnet.co/3NlKj4D

Meta and IBM Launch AI Alliance (WSJ) // https://on.wsj.com/3Ni6NDy

Big VC Funds Are Underperforming Smaller Ones and Their Future Is Dim (Institutional Investor) //

HF Site

YOUTUBE
INSTAGRAM
TWITTER
FACEBOOK
LINKEDIN
TIKTOK